IL17A and cancer: It was reported that the ability of Treg cells to control cancer-associated Th17 cell-mediated inflammation is lost in the course of disease and Treg cells shift from a protective IL-10-producing anti-inflammatory to an IL17-producing cancer-promoting proinflammatory phenotype, with preserved capacity to suppress protective antitumour immune responses31, 32, 33.